CLINICAL_TRIALS
trial_result
· 2025-12-08
Clinical Trial Update: Detection of Graft Versus Host Disease With [18F]F-AraG [Phase 1]
Summary
Phase 1 trial evaluating the PET imaging agent [18F]F-AraG for detecting graft-versus-host disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CellSight Technologies, Inc. | Conditions: Graft Versus Host Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-12-08